ArticleJTO clinical and research reports2025

Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLC.

Arthi Sridhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.